세계의 폐기종 시장 보고서(2025년)

Emphysema Global Market Report 2025

US $ 4,490 ￦ 6,493,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,386,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,279,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 폐기종 시장 규모는 향후 수년간 안정된 성장이 예상됩니다. 2029년에는 CAGR 4.9%로 60억 5,000만 달러로 성장할 것으로 보입니다. 예측기간 동안의 성장은 헬스케어 지출 증가, 환경오염 증가, 진단용 의료기기 수요 증가, 자동차 교통량 증가, 저침습 처치 수요 증가 등에 기인한다고 생각됩니다. 이 기간의 주요 동향에는 새로운 흡입 장치 개발, 전략적 파트너십, 맞춤형 의료, 원격 의료, 흡입 요법 진보, 진행 중인 의료 기술 혁신 등이 포함됩니다.

호흡기 감염의 유병률 증가는 폐기종 시장의 성장을 가속할 것으로 예측됩니다. 호흡기 감염은 부비동, 인후,기도, 폐 등 호흡기 시스템의 다양한 부분에 영향을 미칩니다. 호흡기 감염 증가는 오염, 기후 변화, 항균제 내성, 도시화, 새로운 병원체의 출현 등의 요인에 기인합니다. 이러한 감염은 염증을 유발하고 조직을 손상시키고 기도 폐색을 증가시킴으로써 폐기종을 악화시키고, 이들 모두가 폐 기능의 추가 악화를 초래합니다. 예를 들어, 2024년 11월 미국 질병 예방관리센터(CDC)는 미국에서 결핵 증례 증가를 보고했으며, 2023년에는 전년 대비 15.6% 증가한 9,633건의 결핵 증례가 기록되었습니다. 호흡기 감염은 증가의 길을 따라가고 있으며 폐기종 시장의 성장에 기여합니다.

폐기종 시장 기업은 폐기종을 포함한 만성 폐색성 폐질환(COPD)의 치료를 개선하기 위해 포스포디에스테라아제 3 및 포스포디에스테라제 4의 흡입 이중 억제제와 같은 혁신에 주력 이러한 약물은 기도를 이완시키고 염증을 억제하고 폐 기능을 개선하여 질병 관리를 강화하고 환자의 QOL을 향상 시켰습니다. 2024년 6월, 영국의 제약회사 Verona Pharma plc는 COPD의 유지 치료로서 처음으로 FDA로부터 승인된 PDE3와 PDE4의 듀얼 흡입 억제제인 Ohtuvayre(ensifentrine)를 발매했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 폐기종 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 폐기종 시장 : 성장률 분석
• 세계의 폐기종 시장 실적 : 규모와 성장, 2019-2024년
• 세계의 폐기종 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 폐기종 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 폐기종 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 중심소엽성
• 범소엽성
• 세계의 폐기종 시장 : 치료별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 약
• 치료
• 수술
• 기타
• 세계의 폐기종 시장 : 진단별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 영상 검사
• 폐기능 검사
• 기타
• 세계의 폐기종 시장 : 합병증별, 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 흉부 감염증
• 무기폐
• 심장 문제
• 폐 구멍
• 기타 합병증
• 세계의 폐기종 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 병원 및 클리닉
• 수술센터
• 기타
• 세계의 폐기종 시장, 중심소엽성별 : 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 경도 중심소엽성 폐기종
• 중등도 중심소엽성 폐기종
• 심한 중심소엽성 폐기종
• 세계의 폐기종 시장, 범소엽성별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 경도 범소엽성 폐기종
• 중등 범소엽성 폐기종
• 중증 범소엽성 폐기종

제7장 지역별/국가별 분석

• 세계의 폐기종 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 폐기종 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 폐기종 시장 : 경쟁 구도
• 폐기종 시장 : 기업 프로파일
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Sanofi SA
  • AstraZeneca PLC
  • Novartis International AG

제31장 기타 주요 기업 및 혁신 기업

• GlaxoSmithKline PLC
• Takeda Pharmaceutical Company Limited
• Koninklijke Philips NV
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim
• Mylan NV
• Olympus Corporation
• ResMed Inc.
• Chiesi Farmaceutici SpA
• University of Chicago Medicine(UChicago Medicine)
• Hikma Pharmaceuticals PLC
• United Therapeutics Corporation
• VIDA Diagnostics Inc.
• Kamada Limited
• Pulmonx Corporation

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

• 폐기종 시장(2029년) : 새로운 기회를 제공하는 국가
• 폐기종 시장(2029년) : 새로운 기회를 제공하는 부문
• 폐기종 시장(2029년) : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제36장 부록

JHS

영문 목차

영문목차

Emphysema is a chronic lung disease that causes damage to the air sacs (alveoli) in the lungs, resulting in difficulty breathing. It is a type of chronic obstructive pulmonary disease (COPD), typically caused by smoking or prolonged exposure to air pollutants. As the alveoli weaken and lose their elasticity, air becomes trapped in the lungs, making it difficult to expel carbon dioxide and take in fresh oxygen. This leads to shortness of breath, a chronic cough, and progressively reduced lung function.

The primary types of emphysema are centrilobular and panlobular. Centrilobular refers to damage in the central part of the lung lobule, often seen in centrilobular emphysema. Treatment options for emphysema include medications, therapy, surgery, and other approaches. Diagnosis typically involves imaging tests, lung function assessments, and additional diagnostic procedures. Common complications associated with emphysema include chest infections, lung collapse, heart issues, lung holes, and other related conditions. Treatment typically occurs in hospitals, clinics, surgical centers, and other healthcare facilities.

The emphysema market research report is one of a series of new reports from The Business Research Company that provides emphysema market statistics, including the emphysema industry global market size, regional shares, competitors with the emphysema market share, detailed emphysema market segments, market trends, and opportunities, and any further data you may need to thrive in the emphysema industry. This emphysema market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The emphysema market size has grown strongly in recent years. It will grow from $4.74 billion in 2024 to $4.99 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth during the historic period can be attributed to the rising prevalence of respiratory diseases, the aging population, increased smoking rates, higher levels of air pollution, growing government initiatives, and a larger population of tobacco smokers.

The emphysema market size is expected to see steady growth in the next few years. It will grow to $6.05 billion in 2029 at a compound annual growth rate (CAGR) of 4.9%. The growth during the forecast period can be attributed to rising healthcare spending, increasing environmental pollution, higher demand for diagnostic medical devices, growing vehicular traffic, and a greater demand for minimally invasive procedures. Key trends during this period include the development of new inhalation devices, strategic partnerships, personalized medicine, telemedicine, advancements in inhalation therapies, and ongoing medical innovations.

The increasing prevalence of respiratory infections is expected to drive the growth of the emphysema market. Respiratory infections affect various parts of the respiratory system, such as the sinuses, throat, airways, and lungs. The rising number of respiratory infections can be attributed to factors such as pollution, climate change, antimicrobial resistance, urbanization, and the emergence of new pathogens. These infections can worsen emphysema by causing inflammation, damaging tissues, and increasing airway obstruction, all of which lead to further deterioration of lung function. For example, in November 2024, the Centers for Disease Control and Prevention (CDC) reported a rise in tuberculosis (TB) cases in the U.S., with 9,633 cases recorded in 2023, a 15.6% increase from the previous year. As respiratory infections continue to increase, they contribute to the growth of the emphysema market.

Companies in the emphysema market are focusing on innovations such as inhaled dual inhibitors of phosphodiesterase 3 and phosphodiesterase 4 to improve treatment for chronic obstructive pulmonary disease (COPD), including emphysema. These medications help relax the airways, reduce inflammation, and improve lung function, offering enhanced management of the disease and improving patients' quality of life. For instance, in June 2024, Verona Pharma plc, a UK-based pharmaceutical company, introduced Ohtuvayre (ensifentrine), the first inhaled dual PDE3 and PDE4 inhibitor approved by the FDA for COPD maintenance treatment. This novel inhaled therapy, combining bronchodilator and anti-inflammatory effects, marks the first new inhaled treatment in over two decades and is set to be available through specialty pharmacies.

In October 2023, Aileron Therapeutics, a U.S.-based biopharmaceutical company, acquired Lung Therapeutics for an undisclosed amount. This acquisition allows Aileron to expand its pipeline by gaining access to clinical-stage therapies, such as LTI-03, a novel peptide aimed at treating idiopathic pulmonary fibrosis. Lung Therapeutics, a company focused on developing treatments for lung diseases, has developed therapies for conditions such as emphysema, and this acquisition positions Aileron to further address life-threatening lung diseases that currently have limited treatment options.

Major players in the emphysema market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Mylan N.V., Olympus Corporation, ResMed Inc., Chiesi Farmaceutici S.p.A., University of Chicago Medicine (UChicago Medicine), Hikma Pharmaceuticals PLC, United Therapeutics Corporation, VIDA Diagnostics Inc., Kamada Limited, Pulmonx Corporation, Mereo BioPharma Group PLC, Uptake Medical Corporation, and Verona Pharma PLC.

North America was the largest region in the emphysema market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in emphysema report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the emphysema market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The emphysema market consists of revenues earned by entities by providing services such as diagnosis and screening services, oxygen therapy, pulmonary rehabilitation programs, and home healthcare services. The market value includes the value of related goods sold by the service provider or included within the service offering. The emphysema market also includes sales of bronchodilators, corticosteroids, oxygen therapy devices, nebulizers, and pulmonary rehabilitation products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Emphysema Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on emphysema market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for emphysema ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The emphysema market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Centrilobular; Panlobular
• 2) By Treatment: Medication; Therapy; Surgery; Other Treatments
• 3) By Diagnosis: Imaging Test; Lung Function Test; Other Diagnosis
• 4) By Complications: Chest Infections; Collapsed Lung; Heart Problems; Lungs Hole; Other Complications
• 5) By End-user: Hospitals And Clinics; Surgical Center; Other End-users
• Subsegments:
• 1) By Centrilobular: Mild Centrilobular Emphysema; Moderate Centrilobular Emphysema; Severe Centrilobular Emphysema
• 2) By Panlobular: Mild Panlobular Emphysema; Moderate Panlobular Emphysema; Severe Panlobular Emphysema
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Sanofi S.A.; AstraZeneca PLC; Novartis International AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Emphysema Market Characteristics

3. Emphysema Market Trends And Strategies

4. Emphysema Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Emphysema Growth Analysis And Strategic Analysis Framework

• 5.1. Global Emphysema PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Emphysema Market Growth Rate Analysis
• 5.4. Global Emphysema Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Emphysema Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Emphysema Total Addressable Market (TAM)

6. Emphysema Market Segmentation

• 6.1. Global Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Centrilobular
• Panlobular
• 6.2. Global Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Therapy
• Surgery
• Other Treatments
• 6.3. Global Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Test
• Lung Function Test
• Other Diagnosis
• 6.4. Global Emphysema Market, Segmentation By Complications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chest Infections
• Collapsed Lung
• Heart Problems
• Lungs Hole
• Other Complications
• 6.5. Global Emphysema Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Surgical Center
• Other End-users
• 6.6. Global Emphysema Market, Sub-Segmentation Of Centrilobular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mild Centrilobular Emphysema
• Moderate Centrilobular Emphysema
• Severe Centrilobular Emphysema
• 6.7. Global Emphysema Market, Sub-Segmentation Of Panlobular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mild Panlobular Emphysema
• Moderate Panlobular Emphysema
• Severe Panlobular Emphysema

7. Emphysema Market Regional And Country Analysis

• 7.1. Global Emphysema Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Emphysema Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Emphysema Market

• 8.1. Asia-Pacific Emphysema Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Emphysema Market

• 9.1. China Emphysema Market Overview
• 9.2. China Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Emphysema Market

• 10.1. India Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Emphysema Market

• 11.1. Japan Emphysema Market Overview
• 11.2. Japan Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Emphysema Market

• 12.1. Australia Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Emphysema Market

• 13.1. Indonesia Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Emphysema Market

• 14.1. South Korea Emphysema Market Overview
• 14.2. South Korea Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Emphysema Market

• 15.1. Western Europe Emphysema Market Overview
• 15.2. Western Europe Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Emphysema Market

• 16.1. UK Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Emphysema Market

• 17.1. Germany Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Emphysema Market

• 18.1. France Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Emphysema Market

• 19.1. Italy Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Emphysema Market

• 20.1. Spain Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Emphysema Market

• 21.1. Eastern Europe Emphysema Market Overview
• 21.2. Eastern Europe Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Emphysema Market

• 22.1. Russia Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Emphysema Market

• 23.1. North America Emphysema Market Overview
• 23.2. North America Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Emphysema Market

• 24.1. USA Emphysema Market Overview
• 24.2. USA Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Emphysema Market

• 25.1. Canada Emphysema Market Overview
• 25.2. Canada Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Emphysema Market

• 26.1. South America Emphysema Market Overview
• 26.2. South America Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Emphysema Market

• 27.1. Brazil Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Emphysema Market

• 28.1. Middle East Emphysema Market Overview
• 28.2. Middle East Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Emphysema Market

• 29.1. Africa Emphysema Market Overview
• 29.2. Africa Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Emphysema Market Competitive Landscape And Company Profiles

• 30.1. Emphysema Market Competitive Landscape
• 30.2. Emphysema Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

31. Emphysema Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline PLC
• 31.2. Takeda Pharmaceutical Company Limited
• 31.3. Koninklijke Philips N.V.
• 31.4. Teva Pharmaceutical Industries Ltd.
• 31.5. Boehringer Ingelheim
• 31.6. Mylan N.V.
• 31.7. Olympus Corporation
• 31.8. ResMed Inc.
• 31.9. Chiesi Farmaceutici S.p.A.
• 31.10. University of Chicago Medicine (UChicago Medicine)
• 31.11. Hikma Pharmaceuticals PLC
• 31.12. United Therapeutics Corporation
• 31.13. VIDA Diagnostics Inc.
• 31.14. Kamada Limited
• 31.15. Pulmonx Corporation

32. Global Emphysema Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Emphysema Market

34. Recent Developments In The Emphysema Market

35. Emphysema Market High Potential Countries, Segments and Strategies

• 35.1 Emphysema Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Emphysema Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Emphysema Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료